glp-1 drugs news Americans are taking weight-loss in record numbers GLP-1 Drugs Drop More Than

Because of the complexity and heterogeneity of the pathogenesis of SA, the underlying mechanisms involved in neutrophilic-type SA need further study

Life Technologies)

PLOS ONE 16, e0258800

One such drug is Amgens Maridebart cafraglutide (MariTide, formerly AMG 133)

Safety, Side Effects, and What Evidence Actually Shows Injectable and oral GLP-1 medications carry well-documented side effect profiles from thousands of clinical trial participants: nausea, vomiting, constipation, and potential pancreatitis risk in susceptible individuals

These results were published in February 2025 (Hendershot, Bremmer, Paladino)